Sappi delivered excellent results during the second financial quarter 2022

Commenting on the group’s results, Sappi Chief Executive Officer Steve Binnie said: “I am very proud of the excellent performance during the quarter particularly in light of the impact of Covid-19 in the last two years and the global economic turmoil. Tight global paper markets were the principal factor behind the quarter’s success and enabled the implementation of higher selling prices which offset extraordinary cost inflation. The Russian-Ukrainian conflict triggered renewed volatility in global commodity markets and further disrupted already constrained global supply chains, which intensified cost inflation across all regions and all product segments.

Despite these headwinds we were able to improve EBITDA by 40% on the prior quarter from US$240 million to US$337 million and three-fold over the equivalent quarter in 2021. Net debt was reduced to US$1,793 million (from US$2,070 million a year ago) and earnings per share excluding special items for the quarter was 35 US cents, a further improvement on the 20 US cents in the prior quarter, providing further evidence of the steadily improving profitability of the group.”

Looking forward, Binnie stated: “In light of the favourable operating environment, the group is in a strong position to maintain the recent momentum and the underlying EBITDA for the third quarter should be consistent with that of the second quarter subject to the impacts of the annual maintenance shuts.”

Financial summary for the quarter:
• EBITDA excluding special items US$337 million (Q2 FY21 US$112 million)
• Net debt of US$1,793 million (Q2 FY21 US$2,070 million)
• Profit for the period US$188 million (Q2 FY21 loss of US$23 million)
• EPS excluding special items 35 US cents (Q2 FY21 loss of 1 US cents)
details at: https://cdn-s3.sappi.com/s3fs-public/Q2-FY22-Financial-results-booklet-Final.pdf

Related Posts

Mondi first to offer extensive portfolio of Cradle to Cradle Certified® uncoated fine papers from its European mills

Mondi received the Cradle to Cradle certification at Bronze level for its uncoated fine papers produced in its mills in Austria, Slovakia and Russia. Mondi is thus the first to offer an extensive uncoated fine paper portfolio as Cradle to Cradle Certified® meeting the high standards and demanding requirements of this certification scheme which marks the step from a linear to a circular economy. This includes Mondi´s well-known professional printing brands Color Copy and PERGRAPHICA®, as well as its range of NAUTILUS® branded recycled papers, and a wide office paper portfolio. "We are proud to kick off the year with this strong sustainability achievement underlining our Mondi Action Plan 2030 (MAP2030) commitment to create circular-driven solutions. For many years, Mondi has been a leader, and often a pioneer, in the sustainability of its uncoated fine papers. For example, Color Copy became the world´s first FSCTMcertified colour laser paper in 2005. Thanks to our new Cradle to Cradle certification our customers have a uniquely wide choice of products to support the environment and contribute to the circular economy without sacrificing on quality or price." Devan Naidoo, Marketing and Sales Director at Mondi Uncoated Fine Paper

Metsä Group’s comparable operating result in January–September 2022 was EUR 966 million

January–September 2022 (1–9/2021) *Sales were EUR 5,239 million (4,457). *Operating result was EUR 986 million (652). Comparable operating result was EUR 966 million (694). *Result before taxes was EUR 961 million (616). Comparable result before taxes was EUR 934 million (658). *Comparable return on capital employed was 20.0% (16.4). *Net cash flow from operations was EUR 828 million (596). July–September 2022 (7–9/2021) *Sales were EUR 1,823 million (1,515). *Operating result was EUR 397 million (273). Comparable operating result was EUR 391 million (278). *Result before taxes was EUR 396 million (263). Comparable result before taxes was EUR 385 million (267). *Comparable return on capital employed was 23.5% (18.8). *Net cash flow from operations was EUR 372 million (222).

UPM brings its first clinical product to market – FibDex® wound dressing

FibDex® wound dressing – made from nanofibrillar cellulose by UPM Biomedicals – has taken a significant step in its path to market, as leading medical device distributor Steripolar Oy now sells the product in Finland. FibDex is the first clinical product of renowned forest-based bioindustry company UPM and shows promising signs for future developments, such as cell therapy. ”We are excited to offer this Finnish product, made from Finnish raw material, first in the world to Finnish healthcare professionals and patients,” said Johana Kuncova-Kallio, Director of UPM Biomedicals. “Nanofibrillar cellulose has proven its potential both in the development of cell therapies and in clinical applications, and we are committed to further innovation.” Kaj Dahlström, CEO of Steripolar, added: “We were attracted to the ingenuity of FibDex. We are always looking for products and solutions that offer diverse and pain-free healing, while minimizing damage to the environment.”
Back To Top
×Close search
Search